Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer

By L. Amundadottir, Peter Kraft, R. Stolzenberg-Solomon, C. Fuchs, G. Petersen, A. Arslan, H. Bueno-de-Mesquita, M. Gross, K. Helzlsouer, E. Jacobs and 61 more. Nature Genetics, 2009

695 citations recorded by the source corpus.

Subfields: Hematology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/6032ede125f770d2af6f9fde715583d94947d767

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. Prashanth Rawla
2. M. Rockman

In Oncology

1. Prashanth Rawla

Citations in the corpus

• Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors (2019, result): “Finally, findings of genome-wide association study “Panscan I” showed an association between non-O blood group and pancreatic cancer [165], and their results were then replicated by Rizzato et al [166].”
• The QTN Program and the Alleles That Matter for Evolution: All That’s Gold Does Not Glitter (2011, background): “…the GWAS associations with the largest effects map to loci characterized by strong recent selection, both geographically restricted positive selection (e.g., OCA2: Sulem et al. 2007) and global balancing selection (e.g., the ABO blood group locus: Stajich and Hahn 2005; Amundadottir et al. 2009).”